Dexcom Continuous Glucose Monitoring Systems

Continuous Glucose Monitoring (CGM) systems provide real-time glucose readings, throughout the day and night, allowing people with diabetes to know their glucose levels and trends with a touch of a button. CGM is a unique technology that has been proven through clinical studies to help improve diabetes management and clinical outcomes as well as maintain that improvement over time. If CGM is worn on a near-daily basis, the on-going benefits are:

Reduction in Haemoglobin A1c without increasing low blood glucose events¹
Reduced time spent in the high and low glucose ranges¹
Reduced events of severe hypoglycaemia (<3.1mmol/L)¹
More time in your target glucose ranges¹

NEW Dexcom G6

Dexcom G6 is the latest technology in the Dexcom continuous glucose monitoring (CGM) range.

The need for blood glucose meter calibrations is eliminated, meaning you can make treatment decisions with zero fingerpricks*!
Slimmer+ and water-resistant sensor indicated for 10-day sensor wear!
Approved for use on an Apple or Android compatible smart device^
Patients can share their data with up to 5 followers/loved ones
Approved for use in children 2 years and older
Customised alarms with a fixed 3.1 mmol/L hypo alert feature
Compatible with Tandem t:slim X2 Insulin Pump with Basal-IQ Technology

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Dexcom G5 Mobile

Dexcom G5 Mobile is the first mobile-connected CGM system and is suitable for adults and children as young as two years of age. The device offers wireless Bluetooth technology housed in the device transmitter that allows glucose information to be displayed directly onto a smart phone freeing users from the need to always carry a separate receiver and providing for greater convenience and discretion.

Fully mobile system - CGM results displayed directly on compatible Apple smart device.
Share - allows up to 5 followers to remotely monitor patient’s glucose data as well as view alerts and alarms.
No more need for confirmatory finger prick testing* - dosing decisions can be made directly from Dexcom G5 Mobile CGM data saving users a significant number of fingerprick tests. Two fingerpricks are required per day for calibration.
Alerts and Alarms - users automatically warned when glucose levels go too high or low.

More information at www.nzmsdiabetes.co.nz

_{* If your glucose alerts and readings do not match your symptoms or expectations, you should obtain a fingerprick. 1. JDRF CGM Study Group. Diabetes Care. 2009. 32(11): 2047-2049.}

Dexcom G4 PLATINUM

Our People

Tracy Shores

National Sales Manager

Tracy has a BSc in Chemistry and a Post Graduate Diploma in Business, both from Auckland University. Tracy has held several senior management roles within the pharmaceutical and medical device industries and has worked in the NZ Healthcare industry for over 30 years. Tracy has held several national roles managing teams to deliver key outcomes for their customers and commercial targets.

Kevin Holwill

Territory Manager

Diabetes Division

Kevin graduated with a Diploma in Comprehensive Nursing and completed New Zealand Nursing Council Registration in 1997. He completed his Bachelor of Nursing Degree from Eastern Institute of Technology in Hawkes Bay, New Zealand in 2003. Prior to joining NZMS Kevin worked in various sales roles in both the United Kingdom and New Zealand. His role at NZMS involves managing the sales of our Diabetes Portfolio into the Wellington and Lower North Island territories.

Courtney Giddens

Territory Manager

Diagnostic & Point of Care Division

Courtney graduated with a Bachelor of Science from University of Canterbury in 2010. Prior to joining NZMS Courtney worked at a histology laboratory in Christchurch gaining registration as a qualified medical laboratory technician before moving to the UK, where she worked in an immunohistochemistry laboratory at UCL for 2 years. Her role at NZMS involves the territory management of the South Island and lower North Island, building relationships and offering technical support over a diverse range of diagnostic products.

Debbie Tuck

Territory Manager

Debbie trained and worked as a Dietitian before completing a Post Graduate Diploma in Management Studies at the University of Waikato. She has worked in various sales roles within the healthcare sector including medical nutrition and diabetes. Prior to joining NZMS Debbie worked as a product specialist for Nutricia Ltd responsible for the Paediatric, Allergy and Metabolic portfolios. Her role at NZMS involves managing the sales of Diabetes products throughout the North Auckland, Hawkes Bay and Nelson/Marlborough regions.

Karyne Coker

Teritory Manager

Karyne has spent more than 20 years of her career as a Registered Nurse, both in South Africa and in New Zealand. She has always had a passion for diabetes care, having grown up in a family of diabetics, and becoming a Type 1 herself a few years ago. Karyne is in awe about the range of diabetes technology available today, and is very excited to be part of a team of like-minded, passionate people.

Katie Lee

Territory Manager

Katie graduated from AUT with a Bachelor of Health Science in Nursing. She has a comprehensive background in both public and commercial healthcare. Her career has predominantly focused on training and supporting patients and healthcare professionals within the chronic healthcare setting. Prior to joining NZMS Katie worked in a sales role managing a national renal/dialysis portfolio. Her role at NZMS involves managing the sales of diabetes products throughout the Auckland region.

Igor Obradovic

Product Manager

Diagnostic & Point of Care Division

Igor graduated with a Bachelor of Science degree from the University of Auckland in 2008. Prior to joining NZMS in 2015, he spent 6 years working in medical laboratories with a focus on quality and productivity improvement. His role at NZMS involves managing the product portfolios across the Diagnostic and Diabetes divisions as well as developing and maintaining customer relationships and introducing customers to new products that represent the latest technology in medical diagnostics and immunotherapy based therapeutics.

Diabetes